Enter SynPull, a new synaptosome imaging method developed by David Klenerman, John Danial, and colleagues at the University of Cambridge, England. SynPull combines single-molecule pull-down of ...
A woman captured the moment her grandfather reunited with her grandmother and a video of their heartwarming reunion has gone ...
A University of Minnesota neuroscientist suspected of doctoring images in a highly influential study of Alzheimer’s disease ...
The long-time Glens Falls city firefighter, who was forced to retire early because of early onset Alzheimer's disease, will ...
Nearly every disease has an inflammatory component, but blood tests can't pinpoint inflammation in specific organs or tissues in the human body. Now researchers have developed a method to detect ...
Discover the latest developments in potential ALS treatments with COYA-302 and COYA-303, set to impact the $1.33 billion ...
The new UT Tyler center addressing dementia will operate out of the university's Riter Center on the North Campus on US ...
The University of Texas at Tyler has received a generous $2 million donation from the Byers Family Foundation.
According to researchers at the University of Exeter, the drink may 'improve brain function in older adults by hijacking ...
The FDA last month accepted the application for subcutaneous Leqembi for maintenance dosing, with a target action date of ...
More than 125 guests had the chance to post with the trophies at St James’ Park ahead of the weekend’s FA Cup double header ...
The U.S. Food and Drug Administration (FDA) has approved monthly maintenance dosing for Leqembi (lecanemab), a treatment for early Alzheimer’s disease.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback